A notable advancement in diabetes treatment is emerging with the release of tirzepatide in a 45mg form. This new formulation builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, and provides a https://rishijyio452446.signalwiki.com/2304220/significant_development_tirzepatide_45mg_for_diabetes_regulation